Connect with us


4% THC, 12% CBD: NFL Cannabis Study For Pain Management




The National Football League (NFL) recently announced that they will fund a study to investigate the potential of cannabis-derived compounds in relieving pain. They have now revealed further details about this study. Among the treatment options that participants will be offered is a combination of THC at 4% and CBD at 12%. The researchers believe that this combination will provide the strongest pain-relieving effects while CBD alone will perform dismally, providing similar relief to placebo. For now this is a speculation until the research makes a confirmation.

The NFL has also revealed that it will be partnering with two medical research teams, one of them being the University of California San Diego. The league is keen on understanding the effect of marijuana and CBD on acute pain; most studies that have been conducted in the past have looked into potential benefits for chronic pain.

Last year, the NFL requested for research proposals for the use of cannabinoids in sports-related pain management. Over one hundred applications were sent and the University of California San Diego (UCSD) was among the top two. The league awarded half a million dollars to the two winners each.

The participants will include athletes who are in the prime of their career. Therefore, it is necessary to design the study in a way that will not interfere with the performance of the athletes. Local rugby players will be included in the clinical trial because they are at risk of injuries similar to those of NFL players.

When a player gets an injury and meets the criteria for acute pain level, they will be offered in of the four options of treatment:

  • 4% THC
  • 12% CBD
  • 4% THC & 12% CBD
  • Placebo

The pain level before and after treatment will be assessed using different tools. Level f function and side effects will also be assessed. The researchers have hypothesized that the most effective pain management will be reported by those offered THC and THC in combination with CBD. They have also hypothesized that the 12% CBD will be as effective. Or ineffective, as the placebo in relieving acute pain.

close News!

We’d love to keep you updated with our latest cannabis news, industry interviews, and offers.

We don’t spam! Read our privacy policy for more info.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.

Posts/Pages Sidebar Form

Advertiser Disclosure: is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

Educational & Medical Disclaimer: This information is for educational purposes only. We are not medical professionals, and no information on this website should be construed as medical advice. For more information please view our Educational & Medical Disclaimer.

Minimum Age: To use this website you must be the minimum age as allowed in your jurisdiction. USA visitors must be 21, visitors from Canada must be 18 or 19 years of age depending on the province. It is illegal for a person younger than this to use this website.